2.9228
2.90%
-0.0872
After Hours:
2.86
-0.0628
-2.15%
Aprea Therapeutics Inc (APRE) Stock Split History
Aprea Therapeutics Inc has split its stock 3 times since its initial public offering (IPO). The first stock split occurred on September 13, 2011 with the ratio of 1-for-500, meaning that for 500 shares of APRE owned pre-split, shareholders then owned 1 share. 2 more splits have been implemented since then. The most recent stock split took place on February 13, 2023 on a 1-for-20 basis.
These splits have increased APRE stock's liquidity and made it more appealing to a larger group of investors. However, it's important to remember that these actions only change the number of shares and the price per share with no impact on Aprea Therapeutics Inc's total market capitalization.
For more detailed information of Aprea Therapeutics Inc's stock splits, view the table below:
These splits have increased APRE stock's liquidity and made it more appealing to a larger group of investors. However, it's important to remember that these actions only change the number of shares and the price per share with no impact on Aprea Therapeutics Inc's total market capitalization.
For more detailed information of Aprea Therapeutics Inc's stock splits, view the table below:
APRE stock split list
Date | Split Ratio |
---|---|
2023-02-13 | 1 - for - 20 |
2018-12-27 | 1 - for - 1000 |
2011-09-13 | 1 - for - 500 |
Will Aprea Therapeutics Inc Stock Split in 2024?
The answer will depend on the decisions of the company's managers and market volatility. Aprea Therapeutics Inc has not made an official announcement regarding whether it will enact a stock split or reverse stock split, but it has a history of doing so when APRE stock prices become too high or too low for retail investors. Therefore, the ultimate decisions will certainly be made by Aprea Therapeutics Inc's board of directors. Typically, no action is taken until its price per share reaches a specific threshold.
Stock Splits of Industry Leaders
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):